Cartography Biosciences
Cartography Biosciences61About
What does Cartography Biosciences do?
Cartography Biosciences is a science pipeline platform company developing cancer immunotherapies. They identify and profile antigens at unprecedented scale using single-cell genomics and proteomics to create a comprehensive antigen atlas, enabling the discovery of safer and more effective drug targets. This approach aims to widen the world of treatable cancers by creating precise, broad, and safe therapeutics for patients.
What is Cartography Biosciences's revenue?
StartupHub estimates Cartography Biosciences's annual revenue at $65.9M (range $36.1M to $170.5M, 44% confidence), based on comparable companies in the sector.
What is Cartography Biosciences's valuation?
StartupHub estimates Cartography Biosciences's effective valuation at $1.1B (range $786.6M to $1.5B, 42% confidence), based on comparable companies in the sector.
How much funding has Cartography Biosciences raised?
Cartography Biosciences has raised a total of $150M in funding. The most recent round on record is Strategic Investment.
Where is Cartography Biosciences headquartered?
Cartography Biosciences is headquartered in South San Francisco, California, USA.
When was Cartography Biosciences founded?
Cartography Biosciences was founded in 2021.
What industry does Cartography Biosciences operate in?
Cartography Biosciences operates in Biotechnology, Oncology, Drug Discovery, Pharmaceuticals, Biotech, HealthTech.
No comments yet. Be the first to share your take.